SMYD2 Promotes Hepatocellular Carcinoma Progression by Reprogramming Glutamine Metabolism via c-Myc/GLS1 Axis

Metabolic reprogramming, such as alterations in glutamine metabolism or glycolysis, is the hallmark of hepatocellular carcinoma (HCC). However, the underlying mechanisms are still incompletely elucidated. Previous studies have identified that methyltransferase SET and MYND domain-containing protein...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Kangdi, Ding, Jun, Zhou, Lingfeng, Li, Dazhi, Luo, Jia, Wang, Wenchao, Shang, Mingge, Lin, Bingyi, Zhou, Lin, Zheng, Shusen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9818721/
https://www.ncbi.nlm.nih.gov/pubmed/36611819
http://dx.doi.org/10.3390/cells12010025

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9818721/
https://www.ncbi.nlm.nih.gov/pubmed/36611819
http://dx.doi.org/10.3390/cells12010025

Ejemplares similares